Cited by 119Protease and Inhibitor MechanismsBlood Coagulation and Thrombosis MechanismsRenin-Angiotensin System Studies

A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease

Open access
Zhong, Sheng, Khalil, Raouf A.·2019·Biochemical Pharmacology

Abstract

A Disintegrin and Metalloproteinase (ADAM) is a family of proteolytic enzymes that possess sheddase function and regulate shedding of membrane-bound proteins, growth factors, cytokines, ligands and receptors. Typically, ADAMs have a pro-domain, and a metalloproteinase, disintegrin, cysteine-rich and a characteristic transmembrane domain. Most ADAMs are activated by proprotein convertases, but can also be regulated by G-protein coupled receptor agonists, Ca 2+ ionophores and protein kinase C activators. A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of secreted enzymes closely related to ADAMs. Like ADAMs, ADAMTS members have a pro-domain, and a metalloproteinase, disintegrin, and cysteine-rich domain, but they lack a transmembrane domain and instead have characteristic thrombospondin motifs. Activated ADAMs perform several functions and participate in multiple cardiovascular processes including vascular smooth muscle cell proliferation and migration, angiogenesis, vascular cell apoptosis, cell survival, tissue repair, and wound healing. ADAMs may also be involved in pathological conditions and cardiovascular diseases such as atherosclerosis, hypertension, aneurysm, coronary artery disease, myocardial infarction and heart failure. Like ADAMs, ADAMTS have a wide-spectrum role in vascular biology and cardiovascular pathophysiology. ADAMs and ADAMTS activity is naturally controlled by endogenous inhibitors such as tissue inhibitors of metalloproteinases (TIMPs), and their activity can also be suppressed by synthetic small molecule inhibitors. ADAMs and ADAMTS can serve as important diagnostic biomarkers and potential therapeutic targets for cardiovascular disorders. Natural and synthetic inhibitors of ADAMs and ADAMTS could be potential therapeutic tools for the management of cardiovascular diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bcp.2019.03.033

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Deficiencies in TANGO2 lead to metabolic disorders, and the protein plays an unknown role in Golgi membrane redistribution into the ER.

    “Deficiencies in TANGO2 (transport and Golgi organization protein 2) lead to metabolic disorders, and the protein plays an unknown role in Golgi membrane redistribution into the ER (16, 17).”

    From Accurate prediction of protein structures and interactions using a 3-track network (2021) · cites this paper as [17]

    The ADAMTS Functions section discusses deficiencies and disorders involving ADAMTS proteins, not TANGO2. Searches for TANGO2 and for Golgi membrane redistribution into the ER found no passage in our copy addressing either part of the claim. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

5 of the 208 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [147]Ren P, Hughes M, Krishnamoorthy S, Zou S, Zhang L, Wu D, Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice 2017; 7: 12351. PMC5617887 28955046

Cited by

Sorted by citations

Authors
Zhong, S., & Khalil, R. A.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Khalil, Raouf A.
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2019-06
Volume
164
Pages
188-204
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2923430092
Cited by
119
References
208
Citations by year
2026: 9 · 2025: 26 · 2024: 7 · 2023: 19 · 2022: 27 · 2021: 17 · 2020: 10 · 2019: 4
FWCI
1.39
Type
journal article
Language
en
Open access
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL-65998, HL-111775)
  • Jilin University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
Adam, ADAMTS, proteolytic enzymes, protein shedding, vascular biology, cardiovascular disease, atherosclerosis, hypertension, aneurysm, coronary artery disease, myocardial infarction, heart failure, vascular smooth muscle cell proliferation, angiogenesis, tissue inhibitors of metalloproteinases, small molecule inhibitors, biomarkers, therapeutic target
MeSH terms
Animals, Endothelium, Vascular, Humans, Vascular Diseases, Disintegrins, Thrombospondins, Amino Acid Motifs, ADAM Proteins, Matrix Metalloproteinase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review